• 1
    Grossfeld GD, Li YP, Lubeck DP et al. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor. J Urol 2002; 168: 530535
  • 2
    Taylor LG, Canfield SE, Du XL. Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer. Cancer 2009; 115: 23882399
  • 3
    Mottet N, Bellmunt J, Bolla M et al. EAU Guidelines on Prostate Cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 2011; 59: 572583 [Epub 2011 Jan 25]
  • 4
    Babaian RJ, Donnelly B, Bahn D et al. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol 2008; 180: 19932004
  • 5
    Gotto GT, Yunis LH, Vora K et al. Impact of prior prostate radiation on complications after radical prostatectomy. J Urol 2010; 184: 136142
  • 6
    Wenske S, Quarrier S, Katz AE. Salvage cryosurgery of the prostate for failure after primary radiotherapy or cryosurgery: long-term clinical, functional, and oncologic outcomes in a large cohort at a tertiary referral centre. Eur Urol 2012; [Epub ahead of print]
  • 7
    Williams AK, Martínez CH, Lu C et al. Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer. Eur Urol 2011; 60: 405410
  • 8
    Bahn DK, Lee F, Silverman P et al. Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up. Clin Prostate Cancer 2003; 2: 111114
  • 9
    Ismail M, Ahmed S, Kastner C et al. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients. BJU Int 2007; 100: 760764
  • 10
    Eisenberg ML, Shinohara K. Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure. Urology 2008; 72: 13151318
  • 11
    Ahmed HU, Cathcart P, McCartan N et al. Focal salvage therapy for localized prostate cancer recurrence after external beam radiotherapy. Cancer 2012; 118: 41484155
  • 12
    Bahn D, de Castro Abreu AL, Gill IS et al. Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years. Eur Urol 2012; 62: 5563
  • 13
    Roach M 3rd, Hanks G, Thames H Jr et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006; 65: 965974
  • 14
    Uchio EM, Aslan M, Wells CK et al. Impact of biochemical recurrence in prostate cancer among US veterans. Arch Intern Med 2010; 170: 13901395
  • 15
    Wilt TJ, Brawer MK, Jones KM et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012; 367: 203213. Erratum in: N Engl J Med. 2012 Aug 9; 367 (6): 582
  • 16
    Liu W, Laitinen S, Khan S et al. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med 2009; 15: 559565. Epub 2009 Apr 12. Erratum in: Nat Med. 2009 Jul; 15 (7): 819
  • 17
    Epstein JI, Allsbrook WC Jr, Amin MB et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005; 29: 12281242
  • 18
    Rogers E, Ohori M, Kassabian VS et al. Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels. J Urol 1995; 153: 104110
  • 19
    Arrayeh E, Westphalen AC, Kurhanewicz J et al. Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study. Int J Radiat Oncol Biol Phys 2012; 82: e787793
  • 20
    Pucar D, Hricak H, Shukla-Dave A et al. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence. Int J Radiat Oncol Biol Phys 2007; 69: 6269
  • 21
    Huang WC, Kuroiwa K, Serio AM et al. The anatomical and pathological characteristics of irradiated prostate cancers may influence the oncological efficacy of salvage ablative therapies. J Urol 2007; 177: 13241329; quiz 1591
  • 22
    Wise AM, Stamey TA, McNeal JE et al. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology 2002; 60: 264269
  • 23
    Karavitakis M, Winkler M, Abel P et al. Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens: implications for focal therapy. Prostate Cancer Prostatic Dis 2011; 14: 4652
  • 24
    Ohori M, Eastham JA, Koh H et al. Is focal therapy reasonable in patients with early stage prostate cancer (CAP)? – An analysis of radical prostatectomy (RP) specimens. J Urol 2006; 175 (Suppl.): 507. AUA Annual Meeting, Atlanta; Abstract # 1574
  • 25
    Noguchi M, Stamey TA, McNeal JE et al. Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers. J Urol 2003; 170: 459463
  • 26
    Pisters LL, Rewcastle JC, Donnelly BJ et al. Salvage prostate cryoablation: initial results from the cryo on-line data registry. J Urol 2008; 180: 559563; discussion 563–4
  • 27
    Taira AV, Merrick GS, Galbreath RW et al. Erectile function durability following permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2009; 75: 639648
  • 28
    Ukimura O, Desai MM, Palmer S et al. 3-Dimensional elastic registration system of prostate biopsy location by real-time 3-dimensional transrectal ultrasound guidance with magnetic resonance/transrectal ultrasound image fusion. J Urol 2012; 187: 10801086
  • 29
    Ward JF 3rd, Rewcastle JC, Ukimura O et al. Focal therapy for the treatment of localized prostate cancer: a potential therapeutic paradigm shift awaiting better imaging. Curr Opin Urol 2012; 22: 104108